Mymetics Corp (MYMX)

[bow-tie]

Vvax001 Cancer Vaccine in (Pre) Malignant Cervical Lesions
Sponsors and Collaborators
University Medical Center Groningen
Dutch Cancer Society
ViciniVax B.V
https://clinicaltrials.gov/ct2/show/NCT03141463

Influenza vaccination in healthcare workers; comparison of ...
www.sciencedirect.com/science/article/pii/S...
Mar 13, 2017 · He is shareholder of Mymetics Corporation and ViciniVax Corporation and received personal fees from Mymetics Corporation for scientific advice. AW has been part of the advisory board (consultancy for HIV or viral hepatitis related issues) of ViiV Healthcare, Gilead, Janssen Pharmaceuticals and Bristol-Myers Squibb and received travel support ...
https://www.sciencedirect.com/science/article/pii/S0264410X17301457
Author: W.J. Me

Vicinivax | Company - Management JAN WILSCHUT
www.vicinivax.com/index.php?cat=Company&page=management
ViciniVax was founded by four distinguished scientists from the University Medical Center Groningen; prof Hans Nijman, MD, PhD; prof Toos Daemen, PhD; prof Jan Wilschut, PhD; prof Ate van der Zee, MD, PhD and Alfred Nijkerk, PharmD and biotech entrepreneur from VenGen.[/b ]http://www.vicinivax.com/index.php?cat=company

ViciniVax is a Dutch clinical stage biopharmaceutical company. It is a spin-off from the University Medical Center Groningen, the Netherlands, developing therapeutic cancer vaccines.